Pee Safe raises $32 Mn Series C from OrbiMed

Femtech brand Pee Safe secures $32 Mn Series C funding from OrbiMed to expand offline retail, boost brand marketing and scale across quick commerce.

Pee Safe, a femtech and hygiene brand, has raised $32 Mn (around INR 288 Cr) in a Series C round led by healthcare investor OrbiMed through a mix of primary and secondary share sales. The company will use the funding to deepen its offline presence, boost brand-led marketing, and scale rapidly across quick commerce and leading online marketplaces.​

Pee Safe’s $32 Mn Series C Round

Femtech startup Pee Safe has secured $32 Mn (about INR 288 Cr) in its Series C funding round from OrbiMed, which has also backed online pharmacy Netmeds. The round comprises a combination of primary and secondary share sale, signalling strong investor confidence in the company’s growth trajectory in the women’s hygiene and wellness space.​

The Gurugram-based brand said the newly raised capital will be used to expand its offline retail network, strengthen brand-focused marketing initiatives, and accelerate growth across quick commerce platforms and leading ecommerce marketplaces. Co-founder Rithish Kumar noted that this investment will help the company scale its distribution, especially in offline channels, while simultaneously building momentum across quick commerce and broader ecommerce to reach more consumers at scale.​

Strategic Value From OrbiMed

Along with the capital infusion, OrbiMed is also deepening its strategic involvement with the company. OrbiMed’s senior leaders, Dr Sunny Sharma and Sumona Chakraborty, will be joining Pee Safe’s board, bringing with them deep expertise in scaling healthcare and consumer health brands.​

OrbiMed is a global healthcare-focused investment firm that manages billions of dollars across public and private markets and has backed multiple consumer health and wellness companies. The addition of Sharma and Chakraborty to the board is expected to strengthen Pee Safe’s governance and support its next phase of omni-channel growth in India and beyond.​

Brand Journey, Founders And Product Portfolio

Pee Safe was founded in 2013 by Vikas Bagaria and Srijana Bagaria with the goal of offering affordable, body-friendly sanitary products that reduce health and wellness complications for women. Co-founder Kumar joined the leadership team in 2017, helping broaden the company’s product and distribution strategy.​

Over the years, the brand has evolved into a full-stack hygiene and wellness player with a wide portfolio. Its product range includes organic cotton tampons, breast pads, panty liners, intimate washes for both men and women, wipes, maternity care products and anti-pollution dust masks, with a focus on safe formulations and comfort.​

Competitive Landscape And Femtech Market Tailwinds

Pee Safe operates in a highly competitive sanitary and hygiene products market that has seen a surge of digitally native and retail-first brands. The company competes with homegrown players such as Sirona, Sanfe, Nua Women and Plush, as well as established global giants like Johnson & Johnson and Procter & Gamble that dominate several personal care categories.​

Investor interest in femtech and menstrual hygiene continues to intensify as demand for sanitary and intimate care products rises. According to a Global Market Insights report, the global femtech market was valued at around $60.2 Bn in 2024 and is projected to grow at a compound annual growth rate of about 16% over the next decade, driven by greater awareness and innovation in women’s health solutions.​

Recent deals in the segment highlight this momentum. In 2024, badminton star Saina Nehwal came on board menstrual hygiene brand Naarica as both an investor and brand ambassador, while feminine hygiene startup Plush raised about INR 40 Cr (around $4.6 Mn) in a Series B round led by former Premji Invest senior partner Rahul Garg to expand its offline presence and strengthen its brand.​